Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial (vol 402, pg 1979, 2023)

被引：0
|
作者：
Iglesias, J. F.
Roffi, M.
Losdat, S.
机构：
来源：
LANCET | 2023年 / 402卷 / 10416期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1978 / 1978
页数：1
相关论文
共 50 条
  • [1] Long-term outcomes with biodegradable polymer sirolimus- eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial
    Iglesias, Juan F.
    Roffi, Marco
    Losdat, Sylvain
    Muller, Olivier
    Degrauwe, Sophie
    Kurz, David J.
    Haegeli, Laurent
    Weilenmann, Daniel
    Kaiser, Christoph
    Tapponnier, Maxime
    Cook, Stephane
    Cuculi, Florim
    Heg, Dik
    Windecker, Stephan
    Pilgrim, Thomas
    [J]. LANCET, 2023, 402 (10416): : 1979 - 1990
  • [2] Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial
    Iglesias, Juan F.
    Muller, Olivier
    Heg, Dik
    Roffi, Marco
    Kurz, David J.
    Moarof, Igal
    Weilenmann, Daniel
    Kaiser, Christoph
    Tapponnier, Maxime
    Stortecky, Stefan
    Losdat, Sylvain
    Eeckhout, Eric
    Valgimigli, Marco
    Odutayo, Ayodele
    Zwahlen, Marcel
    Juni, Peter
    Windecker, Stephan
    Pilgrim, Thomas
    [J]. LANCET, 2019, 394 (10205): : 1243 - 1253
  • [3] Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction Insights From the 2-Year Follow-Up of the BIOSCIENCE Trial
    Piccolo, Raffaele
    Heg, Dik
    Franzone, Anna
    Roffi, Marco
    Tuller, David
    Vuilliomenet, Andre
    Muller, Olivier
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Iglesias, Juan F.
    Windecker, Stephan
    Pilgrim, Thomas
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (09) : 981 - 983
  • [4] Comparative efficacy and safety of novel biodegradable polymer sirolimus-eluting stents versus permanent polymer everolimus-eluting stents at 5-year follow-up
    Colleran, R.
    Michel, J.
    Giacoppo, D.
    Cassese, S.
    Joner, M.
    Kastrati, A.
    Byrne, R. A.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 445 - 445
  • [5] 5-year outcomes in patients with acute coronary syndrome treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents
    Iglesias, J. F.
    Heg, D.
    Roffi, M.
    Tueller, D.
    Muller, O.
    Moarof, I
    Cook, S.
    Weilenmann, D.
    Kaiser, C.
    Valgimigli, M.
    Juni, P.
    Windecker, S.
    Pilgrim, T.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 2533 - 2533
  • [6] Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
    Katagiri, Yuki
    Onuma, Yoshinobu
    Lurz, Philipp
    Buszman, Pawel
    Piek, Jan J.
    Wykrzykowska, Joanna J.
    Asano, Taku
    Kogame, Norihiro
    Takahashi, Kuniaki
    Chang, Chun-Chin
    de Winter, Robbert J.
    Serruys, Patrick W.
    Wijns, William
    [J]. EUROINTERVENTION, 2020, 15 (15) : E1366 - +
  • [7] Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
    Pilgrim, Thomas
    Piccolo, Raffaele
    Heg, Dik
    Roffi, Marco
    Tuller, David
    Vuilliomenet, Andre
    Muller, Olivier
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Khattab, Ahmed A.
    Taniwaki, Masanori
    Rigamonti, Fabio
    Nietlispach, Fabian
    Blochlinger, Stefan
    Wenaweser, Peter
    Juni, Peter
    Windecker, Stephan
    [J]. EUROINTERVENTION, 2016, 12 (11) : E1343 - E1354
  • [8] Long-term effect of biodegradable vs. durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial
    Taniwaki, Masanori
    Haner, Jonas Dominik
    Kakizaki, Ryota
    Ohno, Yohei
    Yahagi, Kazuyuki
    Higuchi, Yoshiharu
    Siontis, George C. M.
    Ando, Kenji
    Stortecky, Stefan
    Suzuki, Nobuaki
    Morf, Laura
    Watanabe, Naoki
    Lanz, Jonas
    Ueki, Yasushi
    Otsuka, Tatsuhiko
    Biccire, Flavio Giuseppe
    Sakurada, Masami
    Losdat, Sylvain
    Raber, Lorenz
    [J]. EUROPEAN HEART JOURNAL, 2024,
  • [9] Long-term follow-up of patients with ST-Segment elevation myocardial infarction treated with sirolimus-eluting stents
    Shah, Anuj R.
    Tandon, Himanshu
    Navare, Sachin
    Maksoud, Aziz
    Mirza, ZuIfqar
    Mather, Jeff
    Mennett, Roger
    Mennett, Roger
    Kiernan, Francis
    Mckay, Raymond
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 243A - 243A
  • [10] Five-year outcomes in patients with diabetes mellitus treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents
    Iglesias, J. F.
    Heg, D.
    Roffi, M.
    Tueller, D.
    Lanz, J.
    Rigamonti, F.
    Muller, O.
    Moarof, I.
    Cook, S.
    Weilenmann, D.
    Kaiser, C.
    Valgimigli, M.
    Jueni, P.
    Windecker, S.
    Pilgrim, T.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1257 - 1257
12345